Rediscovery of known natural compounds: Nuisance or goldmine?

被引:59
作者
Tulp, M
Bohlin, L
机构
[1] Uppsala Univ, Div Pharmacognosy, Dept Med Chem, Biomed Ctr, SE-75123 Uppsala, Sweden
[2] Solvay Pharma, Dept Intellectual Property & Sci Informat, Res Labs Weesp, NL-1381 CP Weesp, Netherlands
关键词
D O I
10.1016/j.bmc.2005.05.067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Do all natural compounds have a distinct biological activity, or are most of them merely biosynthetic debris? Many natural compounds have important biological functions, and certainly many more of the ample 200,000 currently known will ultimately prove to be more than just 'secondary metabolites'. The question is how to select the most promising candidates for potential new drugs. 'Rediscovery' of known natural compounds is regarded as a nuisance or disappointment by scientists involved with the identification of novel compounds. The other side of the coin, however, is that the discovery that a particular compound occurs in unrelated species can be a valuable clue toward the identification of a novel receptor or enzyme. Here, we put forward the hypothesis that when a natural compound occurs in unrelated species, it must have an important biological function by interacting with a specific molecular target. This is because it is extremely improbable that in nature one particular compound is synthesized in totally unrelated species for no reason at all. For many compounds occurring in unrelated species, it is already known that they act on specific molecular targets. For others, it is just known that they occur in different species. In some cases, biological activities are known but not the underlying mechanisms of action. It is from this category of compounds that important discoveries are likely to be made. Some (around 70) of them were identified. They represent important clues from nature offering an alternative approach to the classical screening of large numbers of compounds. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5274 / 5282
页数:9
相关论文
共 26 条
[1]   Evidence for the involvement of vanilloid receptor in the antinociception produced by the dialdeydes unsaturated sesquiterpenes polygodial and drimanial in rats [J].
Andre, E ;
Ferreira, J ;
Malheiros, A ;
Yunes, RA ;
Calixto, JB .
NEUROPHARMACOLOGY, 2004, 46 (04) :590-597
[2]  
[Anonymous], 2000, ROMPP ENCY NATURAL P
[3]   Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators [J].
Berry, MD .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (02) :257-271
[4]   Batrachotoxin alkaloids from passerine birds:: A second toxic bird genus (Ifrita kowaldi) from New Guinea [J].
Dumbacher, JP ;
Spande, TF ;
Daly, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :12970-12975
[5]   Vanillins - a novel family of DNA-PK inhibitors [J].
Durant, S ;
Karran, P .
NUCLEIC ACIDS RESEARCH, 2003, 31 (19) :5501-5512
[6]   Neuroprotective effect of γ-glutamylethylamide (theanine) on cerebral infarction in mice [J].
Egashira, N ;
Hayakawa, K ;
Mishima, K ;
Kimura, H ;
Iwasaki, K ;
Fujiwara, M .
NEUROSCIENCE LETTERS, 2004, 363 (01) :58-61
[7]   Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats [J].
Farvin, KHS ;
Anandan, R ;
Kumar, SHS ;
Shiny, KS ;
Sankar, TV ;
Thankappan, TK .
PHARMACOLOGICAL RESEARCH, 2004, 50 (03) :231-236
[8]  
Furlow B, 2001, NEW SCI, V169, P30
[9]   Study on the organoleptic intensity scale for measuring oral malodor [J].
Greenman, J ;
Duffield, J ;
Spencer, P ;
Rosenberg, M ;
Corry, D ;
Saad, S ;
Lenton, P ;
Majerus, G ;
Nachnani, S ;
El-Maaytah, M .
JOURNAL OF DENTAL RESEARCH, 2004, 83 (01) :81-85
[10]  
Harborne JB., 1999, PHYTOCHEMICAL DICT H, V2nd